Hide Board Information

Show Board Information

Tianyin Pharmaceutical Co. TPI

Board Mod: Add me as mod

Asst Mods:

Last Post: 02/27/2018 11:42:00 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

1. TPI Company Profile

    

2. TPI Time & Sales

    

3. TPI Recent News

    

4. TPI Filings

    

5. TPI Financials

    

6. TPI Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	https://stockzoa.com/ticker/tpi/	DR. TADX	02/27/2018 11:42:00 PM
7	TPI Stock year to date has changed -2.74%	Jake13	02/24/2015 9:25:05 AM
6	TPI 0.71 Tianyin Pharmaceutical Co. Stock Charts	chartguy89	02/24/2015 8:31:28 AM
5	TPI Stock year to date has changed -25.32%	Jake13	11/26/2014 11:44:00 AM
4	TPI Year to date has changed -26.58% percent.	Jake13	11/12/2014 12:30:02 PM
3	TPI 0.58 Tianyin Pharmaceutical Co. Stock Charts	chartguy89	11/12/2014 11:05:45 AM
2	TPI 0.58 Tianyin Pharmaceutical Co. Stock Charts	chartguy89	11/11/2014 11:51:27 AM
1	TPI Year to date has changed -26.58% percent.	Jake13	11/11/2014 10:58:22 AM

Recent Articles

• FIFA Faces Growing Pressure to End Partnership with Coca-Cola
• FIFA Faces Calls to End Partnership with Coca-Cola Amid Health Concerns
• Silicon Labs and Wirepas Revolutionizing Industrial IoT Solutions
• Exciting Conclusion of the Taklimakan Rally 2025: A Race to Remember
• Envision Energy and Marubeni Forge Path for Green Ammonia
• Innovative Solutions for Caregiver Burnout by Caily
• Envision Energy Teams Up with Marubeni for Sustainable Future
• Innovative Partnership to Introduce Sustainable Biosurfactants
• Arctech's Five-Year Journey in Solar Innovation and Growth
• Nutex Health Shares Details for Virtual Annual Meeting Access
• Explore Your Rights: Join Iovance Biotherapeutics Class Action
• China's Journey to Technological Prowess and Global Contributions
• Univest Securities, LLC Takes Center Stage at Japan GO IPO Summit
• Jenscare Unveils Groundbreaking Results from Recent Studies
• Innovative Treatment Shows Promise for Advanced Gastric Cancer
• Innovent Biologics Advances IBI354 for Cancer Treatment
• Innovent Biologics Unveils Promising Phase 1 Results for IBI343
• Innovative MEA System by Sony, SCREEN, and VitroVo Launches
• Transformative Advances in CNS Cell Therapy by XellSmart
• Trust3 AI Emerges as a Leader in Trusted AI Solutions
• Bella Sun Luci Expands Internationally at Gulfood Expo
• Extendicare Expands Care with Purchase of Nine Facilities
• Celebrating Exchange: BridgeUSA Tour Enhancing Cultural Ties and Economy
• Cognizant Honored for Excellence in AI-Powered Transformations
• EVA Air Enhances Flight Safety Through IATA Partnership
• How AI is Transforming the Financial Services Landscape
• MY DR NOW Expands Footprint with New Clinic Opening
• Investors Eye Open Lending Corporation Legal Action for Justice
• Atlas Ocean Voyages Introduces Exclusive Expedition Offer
• Semilux's Path to Compliance Following Nasdaq Notification
• DeFi Development Corp. Achieves Exceptional Growth in May 2025
• Nxera Pharma Secures $15 Million from Neurocrine's Advancement
• Ascentage Pharma Unveils Promising Data on Lisaftoclax at ASCO
• ASCO 2025 Highlights: Alrizomadlin's Impact on Solid Tumors
• CW Bancorp Announces Quarterly Dividend for Shareholders
• AWC Unveils Comprehensive National Guide for Mass Timber
• Bipartisan Dialogue Highlights at the Kennedy Institute Event
• Major Shareholder Vote Removes Key Board Member at Silver Star
• Indulge in Father's Day Delights at Empire Steak House
• New Board Appointment Enhances Parex Resources' Leadership
• Understanding the Class Action Against Iovance Biotherapeutics
• Investors Pursue Legal Action Against Krispy Kreme, Inc. DNUT
• Act Now: Important Updates on BigBear.ai Holdings Legal Action
• Eupraxia Pharmaceuticals Transforms Shareholder Engagement and Leadership
• Empowering Conversations: The Future of Black Communities
• Unlock Your Earnings Potential with Fanshash Cloud Mining Today
• Hilco Streambank Seeks Offers for CoreSpace Data Center Assets
• Kura Oncology and Kyowa Kirin Celebrate Ziftomenib Breakthroughs
• FTI Consulting Welcomes Mark Gossington to Risk Management Team
• Highland Opportunities and Income Fund Unveils Monthly Payout Plans